For some individuals with epilepsy, alternative approaches to weight management may be more appropriate, and this should be discussed openly with your medical team to identify the safest and most effective strategy for your individual circumstances
Mounjaro, Ozempic, Rybelsus, Wegovy and Zepbound remain approved by the U.S
In a study published in NEJM SURMOUNT 5*, an international comparative open-label, controlled trial, adult participants with obesity but without type 2 diabetes the 2 agents were compared in maximally tolerated recommended doses
Magnesium: One study found that birth control may lead to lower levels of minerals like magnesium [21], and symptoms of magnesium deficiency include fatigue and muscle cramps [29]
What the Research Shows Weight Loss and Joint Load Reduction The SURMOUNT-1 trial [1] demonstrated that tirzepatide at the 15mg maintenance dose produced average weight loss of 22.5% over 72 weeks in adults with obesity